Meet the PulseSelect™ Pulsed Field Ablation (PFA) System
The PulseSelect™ PFA System is setting a new standard in safety for paroxysmal and persistent atrial fibrillation ablation supported by 15 years of robust pre-clinical and clinical evidence. The PulseSelect™ PFA System offers a differentiated approach to pulsed field ablation that can be implemented across workflows, driving safe, effective, and efficient procedures.
Unmatched safety
Engineered with differentiated safety features from 15 years of PFA research and backed by the results of the safest IDE AF ablation trials to date.
Consistent efficiency
Rapid, effective PVI through consistent and predictable energy delivery and catheter maneuverability.
Simplified adaptability
Seamless transition to PFA with freedom to adapt to your preferred workflow.
Discover the PulseSelect ™ PFA System design and features
Setting a new standard in safety
PulseSelect™ PFA System
Differentiated system safety features developed over 15 years of PFA research
1 - Test pulse for proximity detection to phrenic nerve
2 - R-wave gating for synchronisation of energy delivery
3 - Automatic overcurrent detection for safe energy delivery
Engineered for efficiency
PulseSelect™ PFA Catheter
4 - 9 electrodes built to sense, ablate and pace
5 - 25mm diameter loop
6 - 9Fr shaft with bidirectional steering
Fixed electrode spacing
to produce a reliable field for predictable and consistent contiguous energy delivery
20-degree forward tilt
to ensure more consistent uniform tissue contact
FlexCath Contour™ Steerable Sheath - 10 Fr
Steering therapy with confidence
7 - Braided bidirectional shaft design provides catheter support and resistance to kinking
8 - Smooth sheath-dilator transition with transseptal crossing indication
9 - Robust adjustment knob and rounded handle
10 - Two tip length options to enable alignment with RIPV in difficult anatomies
PULSED AF clinical trial1
PULSED AF evaluated the safety and effectiveness of the PulseSelect™ PFA system for the treatment of patients with paroxysmal and persistent atrial fibrillation and resulted in one of the lowest safety event rates of any AF ablation IDE trial to date.
References
1
Verma A, Haines DE, Boersma LV, et al. Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial. Circulation. May 9, 2023; 147(19): 1422-1432.
Product is CE marked according to law.
